首页> 外文期刊>International braz j urol >Comparison of different postoperative paın managements in patients submitted to transperitoneal laparoscopic renal and adrenal surgery
【24h】

Comparison of different postoperative paın managements in patients submitted to transperitoneal laparoscopic renal and adrenal surgery

机译:不同术后Paın管理在提交调翻腹腔镜肾癌和肾上腺手术的患者中的比较

获取原文
       

摘要

ABSTRACTPurpose:We compared the effects of local levobupivacaine infiltration, intravenous paracetamol, intravenous lornoxicam treatments on postoperative analgesia in patients submitted to transperitoneal laparoscopic renal and adrenal surgery.Materials and Methods:Sixty adult patients 26 and 70 years who underwent laparoscopic renal and adrenal surgery were randomized into three groups with 20 patients each: Group 1 received local 20mL of levobupivacaine 0.25% infiltration to the trocar incisions before skin closure. In group 2, 1g paracetamol was given to the patients intravenously 30 minutes before extubation and 5g paracetamol was given intravenoulsy in the 24 postoperative period. In group 3, 8mg lornoxicam i.v. was given 30 minutes before extubation and 8mg lornoxicam i.v. was given in the 24 postoperative period. In the postoperative period, pain scores, cumulative tramadol, and additional pethidine consumption were evaluated.Results:Postoperative pain scores significantly reduced in each group (p 0.05). Although pain levels of the groups were not significantly different at 1, 2, 4, 8, 12 and 24 hours postoperatively, cumulative tramadol consumptions were higher in group 1 than the others. (Group 1 = 370.6 ± 121.6mg, Group 2: 220.9 ± 92.5mg, Group 3 = 240.7 ± 100.4mg.) (p 0.005). The average dose of pethidine administered was significantly lower in groups 2 and 3 compared with group 1 (Group 1: 145mg, Group 2: 100mg, Group 3: 100mg) (p = 0.024).Conclusions:Levobupivacaine treated group required significantly more intravenous tramadol when compared with paracetamol and lornoxicam groups in patients submitted to transperitoneal laparoscopic renal and adrenal surgery.
机译:摘要:我们比较了局部左旋蛋白浸润,静脉扑热息痛,静脉内洛昔康治疗对术后镇痛的患者术后腹腔镜肾癌和肾上腺手术的疗效。材料和方法:60例接受腹腔镜肾癌和肾上腺手术的60岁及70岁用20例患者随机分为三组:第1组接受局部20ml左杆菌卡因0.25%渗透到皮肤闭合前的套管针切口。在第2组中,在拔管前30分钟给予患者1g扑热息痛,并在术后24个期间给予5g乙酰氨基酚。在第3组,8mg林昔康I.v.在拔管前30分钟,8mg Lornoxicam i.v.在术后24个术后。在术后期间,评估疼痛评分,累积曲马多和额外的哌替啶消费。结果:每组术后疼痛评分显着降低(P <0.05)。虽然术后1,2,4,8,12和24小时,群体的疼痛水平没有显着差异,但累积的曲马多的消费比其他累积曲折的消耗较高。 (第1组= 370.6±121.6mg,第2组:220.9±92.5mg,组3 = 240.7±100.4mg。)(P <0.005)。与第1组相比,施用的平均剂量的哌替丁施用的剂量显着降低(第1组(第145mg,第2组:100mg,3:100mg,第3组)(P = 0.024)。结论:Levobupivacaine治疗组所需的静脉内曲马多与提交给翻盖腹腔镜肾和肾上腺手术的患者的亚乙酰氨基酚和洛诺克西癌群组进行比较。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号